Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Biswa Pratim Das, Purakayastha"'
Autor:
R. S. Gupta, Ambica Baru, Swati Sharma, Saumyabrata Mazumdar, Nupur Mehrotra Arora, Sameena Khan, Prabuddha Kumar Kundu, Biswa Pratim Das Purakayastha
Publikováno v:
ASSAY and Drug Development Technologies. 19:361-372
The latest advancements in oncology are majorly focused on immuno-oncology (I-O) therapies. However, only ∼7% of drugs are being approved from the preclinical discovery phase to phase 1. The most challenging issues in I-O are the development of act
Autor:
Ambica, Baru, Swati, Sharma, Biswa Pratim Das, Purakayastha, Sameena, Khan, Saumyabrata, Mazumdar, Reeshu, Gupta, Prabuddha K, Kundu, Nupur Mehrotra, Arora
Publikováno v:
Assay and drug development technologies. 19(6)
The latest advancements in oncology are majorly focused on immuno-oncology (I-O) therapies. However, only ∼7% of drugs are being approved from the preclinical discovery phase to phase 1. The most challenging issues in I-O are the development of act
Autor:
Sameena Khan, Nupur Mehrotra Arora, Ambica Baru, Prabuddha Kumar Kundu, Saumyabrata Mazumdar, Swati Sharma, Biswa Pratim Das Purakayastha, R. S. Gupta
The formation of three-dimensional spheroid tumor model using the scaffold-based platforms has been demonstrated over many years now. 3D tumor models are generated mainly in non-scalable culture systems, using synthetic and biological scaffolds. Many
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf4b11faf7317b1f2d63ec8b4525617d
https://doi.org/10.1101/2020.12.21.423825
https://doi.org/10.1101/2020.12.21.423825